[{"Assets_0_Q3_USD":112618000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-25022000.0,"NetIncomeLoss_1_Q3_USD":-8280000.0,"NetIncomeLoss_3_Q3_USD":-24370000.0,"StockholdersEquity_0_Q3_USD":63472000.0,"Ticker":"TMDX","CIK":"1756262","name":"TRANSMEDICS GROUP, INC.","OfficialName":"TransMedics Group Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"632779019.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20191108"}]